ADVANCED SOLID TUMOR (PHASE 1)

Clinical trials for ADVANCED SOLID TUMOR (PHASE 1) explained in plain language.

Never miss a new study

Get alerted when new ADVANCED SOLID TUMOR (PHASE 1) trials appear

Sign up with your email to follow new studies for ADVANCED SOLID TUMOR (PHASE 1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

Experimental cancer drug begins first human testing

Disease control Not yet recruiting

This is the first study in humans to test a new cancer drug called T320. The trial aims to find the safest dose and check for side effects in 150 patients with advanced solid tumors who have no effective standard treatments left. Patients will receive T320 injections every two we…

Matched conditions: ADVANCED SOLID TUMOR (PHASE 1)

Phase: PHASE1 • Sponsor: Nanolattix Biotechnology Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

ADVANCED SOLID TUMOR (PHASE 1)

Get alerted when new ADVANCED SOLID TUMOR (PHASE 1) trials appear

Experimental cancer drug begins first human testing